参考文献/References:
[1] Karki R,Sharma BR,Tuladhar S,et al.Synergism of TNF-α and IFN-γ triggers inflammatory cell death,tissue damage,and mortality in SARS-CoV-2 infection and cytokine shock syndromes[J].Cell,2021,184(1):149-168.
[2] Basheer M,Saad E,Kananeh M,et al.Cytokine patterns in COVID-19 patients:Which cytokines predict mortality and which protect against?[J].Curr Issues Mol Biol,2022,44(10):4735-4747.
[3] Ng WH,Tang PCH,Mahalingam S,et al.Repurposing of drugs targeting the cytokine storm induced by SARS-CoV-2[J].Brit J Pharmacol,2023,180(2):133-143.
[4] Kulanthaivel S,Kaliberdenko VB,Balasundaram K,et al.Tocilizumab in SARS-CoV-2 patients with the syndrome of cytokine storm:A narrative review[J].Rev Recent Clin Tria,2021,16(2):138-145.
[5] Leisman DE,Ronner L,Pinotti R,et al.Cytokine elevation in severe and critical COVID-19:A rapid systematic review,meta-analysis,and comparison with other inflammatory syndromes[J].Lancet Respir Med,2020,8(12):1233-1244.
[6] Chen R,Lan Z,Ye J,et al.Cytokine storm:The primary determinant for the pathophysiological evolution of COVID-19 deterioration[J].Front Immunol,2021,12:589095.
[7] 中国研究型医院学会危重症医学专业委员会,中国医药教育协会重症医学委员会.西维来司他纳临床应用专家共识[J].中国研究型医院,2022,9(1):9-13.
[8] Cokluk E,Doanay S,Ramazan-Sekerolu M,et al.Investigation of the effect of melatonin administration on inflammatory mediators MMP-2,TGF-β and VEGF levels in rats with sepsis[J].Int J Clin Pract,2021,75(11):e14832.
[9] Jones TK,Reilly JP,Anderson BJ,et al.Elevated plasma levels of matrix Metalloproteinase-3 and tissue-inhibitor of matrix metalloproteinases-1 associate with organ dysfunction and mortality in sepsis[J].Shock,2022,57(1):41-47.
[10] Fiotti N,Mearelli F,Di-Girolamo FG,et al.Genetic variants of matrix metalloproteinase and sepsis:The need speed study[J].Biomolecules,2022,12(2):279-284.
[11] Serrano-Gomez S,Burgos-Angulo G,Nino-Vargas DC,et al.Predictive value of matrix metalloproteinases and their inhibitors for mortality in septic patients:A cohort study[J].J Intensive Care Med,2020,35(1):95-103.
[12] Feng L,Liu Y,Chen M,et al.Matrix metalloproteinase 14 and plasma kallikrein 1 may be potential biomarkers in the diagnosis and treatment of sepsis:A proteomics and bioinformatics analysis[J].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,2022,34(7):676-681.
[13] 佘育纯,路 勇,王建龙.血清基质金属蛋白酶-9、二胺氧化酶、Toll样受体9与急性胰腺炎患者疾病严重程度及肠黏膜屏障损伤相关性分析[J].陕西医学杂志,2023,52(3):292-296.
[14] Mohammadi A,Balan I,Yadav S,et al.Post-COVID-19 pulmonary fibrosis[J].Cureus, 2022,14(3):e22770.
[15] 梁 红,霍红艳.右美托咪定对盲肠结扎穿孔术诱导的脓毒症大鼠急性肺损伤保护作用及其与磷酸化JAK激酶2/酪氨酸磷酸化通路的关系[J].陕西医学杂志,2023,52(1):12-17.
[16] Zhu YK,Liu X,Wang H,et al.Interactions between monocytes and smooth-muscle cells can lead to extracellular matrix degradation[J].J Allergy Clin Immunol Dec,2001,108(6):989-996.
[17] 甘世伟,章晓红,陈 红.白介素6与冠状病毒肺炎关系的研究进展[.J].中华临床医师杂志,2020,14(7):573-576.
[18] Hama-Amin BJ,Kakamad FH,Ahmed GS,et al.Post COVID-19 pulmonary fibrosis:A meta-analysis study[J].Ann Med Surg(Lond),2022,77:103590.
[19] Bormann T,Maus R,Stolper J,et al.Role of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice[J].Respir Res,2022,23(1):180.
[20] Chuliá-Peris L,Carreres-Rey C,Gabasa M,et al.Matrix metalloproteinases and their inhibitors in pulmonary fibrosis:EMMPRIN/CD147 comes into play[J].Int J Mol Sci,2022,23(13):6894.